ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Ocrevus subkutan 920 mg/23 ml, Injektionslösung - 
68988001 Roche Pharma (Schweiz) AG
Ocrevus subkutan 920 mg/23 ml, Injektionslösung15.11.2024
  15.11.2024
Ocrelizumab (L04AA36) 
WHO-DDD14.11.2029
01.99. 
01.99. 
A  
Yes 
IP 
10648.94Yes
    
10 %11233.60
7680689880013Biotechnologika
  
Composition
ocrelizumabum 920 mg, hyaluronidasum humanum ADNr, trehalosum dihydricum, acidum aceticum glaciale, methioninum, polysorbatum 20, natrii acetas trihydricus, aqua ad iniectabile ad solutionem pro 23 ml corresp. natrium 8.4 mg.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Ocrelizumabum920mg / 23ml
BAG: Active AgentDose
Ocrelizumabum920 mg
 
Inactive agents
Acidum Aceticum Glaciale
Hyaluronidasum Humanum Adnr
Methionine
Sodium Acetate Trihydrate
Polysorbatum 20
Trehalosum Dihydricum
 
Source
Data was imported : 04.12.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home